AI Article Synopsis
- Medication adherence is a major public health challenge in treating severe psychiatric disorders like schizophrenia, leading to the exploration of new treatment methods, such as implantable medication delivery systems.
- A study evaluated the attitudes of psychiatric patients and their families towards these implantable systems, including individuals with schizophrenia and mood disorders.
- Results show significant support for the implantable option, with nearly half of the patients and over 74% of family members expressing acceptance, suggesting it could be a viable alternative to traditional medication methods.
Article Abstract
Introduction: Medication is a necessary part of treatment for severe psychiatric illnesses such as schizophrenia and nonadherence to prescribed medication is one of the most important public health issues in psychiatry today. The devastating consequences of nonadherence have motivated the development of novel therapeutic strategies, including a new long-term implantable medication delivery system.
Methods: The current study assesses attitudes towards implantable medication in psychiatric patients and their family members. Patients included in the study had diagnoses of Schizophrenia, Schizoaffective Disorder, Mood or Anxiety related disorders.
Results: 49.62% of patients and 74.47% of family members endorse support for implantable medication.
Conclusions: This study demonstrates that implants may be an acceptable alternative to oral and injectable medication for a subset of psychiatric patients and their families.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.schres.2008.05.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!